---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-255981"
form_type: "8-K"
ticker: "GRDN"
cik: "0001802255"
company_name: "Guardian Pharmacy Services, Inc."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T02:06:53.147476+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Guardian Pharmacy Q3 revenue $314M (+20% YoY); Adj. EBITDA $23M (+20%); guides FY24

## Summary
- Revenue of $314.4M (+20% YoY) driven by organic growth and Heartland Pharmacy acquisition.
- Net loss of $105.8M due to $122.4M share-based comp from IPO; Adj. EBITDA of $23.0M (+20% YoY).
- Resident count of 180,000 at quarter-end, up 12% YoY.
- FY 2024 guidance: revenue $1.205B-$1.215B, Adjusted EBITDA $86.5M-$87.0M.
- Completed a small acquisition in Q3, entering a new market with a strong operating team.

## SEC filing metadata
- accession: 0001193125-24-255981
- form_type: 8-K
- ticker: GRDN
- cik: 0001802255
- company_name: Guardian Pharmacy Services, Inc.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802255/000119312524255981/0001193125-24-255981-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802255/000119312524255981/d895150d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-255981
- JSON: https://secwatch.observer/filing/0001193125-24-255981.json
- Plain text: https://secwatch.observer/filing/0001193125-24-255981.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.